Presence of SARS-CoV-2 transcripts in the choroid plexus of MS and non-MS patients with COVID-19
Although primarily targeting the respiratory system, coronavirus disease 2019 (COVID-19) affects the CNS in up to 80% of patients.[1][1] Yet, findings on COVID-19 neuropathology have been conflicting: autopsy reports range from inflammatory CNS syndromes, cerebrovascular events,[1][1] and
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
March 2021
|
| In: |
Neurology: Neuroimmunology & Neuroinflammation ; official journal of the American Academy of Neurology
Year: 2021, Volume: 8, Issue: 2, Pages: 1-5 |
| ISSN: | 2332-7812 |
| DOI: | 10.1212/NXI.0000000000000957 |
| Online Access: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1212/NXI.0000000000000957 Verlag, lizenzpflichtig, Volltext: https://nn.neurology.org/content/8/2/e957 |
| Author Notes: | Vidmante Fuchs, Michael Kutza, Sven Wischnewski, Nikolaus Deigendesch, Luc Lutz, Laila Kulsvehagen, Gerda Ricken, Ludwig Kappos, Alexandar Tzankov, Simon Hametner, Stephan Frank, Lucas Schirmer and Anne-Katrin Pröbstel |
| Summary: | Although primarily targeting the respiratory system, coronavirus disease 2019 (COVID-19) affects the CNS in up to 80% of patients.[1][1] Yet, findings on COVID-19 neuropathology have been conflicting: autopsy reports range from inflammatory CNS syndromes, cerebrovascular events,[1][1] and |
|---|---|
| Item Description: | Gesehen am 18.08.2021 |
| Physical Description: | Online Resource |
| ISSN: | 2332-7812 |
| DOI: | 10.1212/NXI.0000000000000957 |